Please assess the completion status of the following clinical trial:

Trial Title: Low-molecular-weight Heparin (LMWH) Versus Unfractionated Heparin (UFH) in Pregnant Women With Recurrent Abortion Secondary to Antiphospholipid Syndrome

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with a minimum of three consecutive pregnancy losses before 10 weeks gestation~* Positive lupus anticoagulant and/or anticardiolipin antibodies (IgG and IgM) on at least two occasions twelve weeks apart .~* Age between 19 - 37 years,~* Body mass index between 19-30~Exclusion Criteria:~* Parental chromosomal abnormalities~* Uterine abnormalities~* Luteal phase defect~* Systemic lupus erythematosus~* Previous thromboembolism~* Sensitivity to aspirin.

- Gender: FEMALE
- Minimum Age: 19 Years
- Maximum Age: 37 Years
- Healthy Volunteers: f

Study Arms:
- enoxaparin 40 mg plus low dose aspirin (Type: EXPERIMENTAL): None
- Heparin calcium 5,000 U twice daily plus low dose aspirin (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).